Brief: GNI Group unit gets manufacture and marketing approval of Etuary in China

GNI

03/08/2016 06:46

Aug 3 (Reuters) - GNI Group Ltd   2160.T :  
     
    * Says its unit Beijing Continent Pharmaceuticals Co., Ltd. 
obtained the manufacture and marketing approval of Etuary for 
the treatment of idiopathic pulmonary fibrosis in China 
 
     
     
    Source text in Japanese:https://goo.gl/lUyccM 
    Further company coverage: 2160.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))